期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

复发性子宫内膜癌的诊断与治疗进展

原文传递
导出
摘要 复发性子宫内膜癌通常发生于初始治疗后2-3年。初治后通过妇科检查、血清CA125检测以及影像学检查等手段来实现子宫内膜癌复发的早期诊断。复发性子宫内膜癌的治疗手段包括手术、放疗、激素治疗、化疗、基因靶向治疗以及生物分子制剂,复发病灶的位置和范围、患者体力状态、初始治疗史、肿瘤组织病理学类型和分级及激素受体情况等因素主要决定了复发性子宫内膜癌的治疗方法的综合选择和治疗方案的个体化制定。
作者 蒋可平 郑建华
机构地区 哈尔滨医科大学附属第一临床医院
出处 《中国妇产科临床杂志》 CSCD 北大核心 2015年第5期468-470,共3页 Chinese Journal of Clinical Obstetrics and Gynecology
关键词 复发性子宫内膜癌 诊断 综合治疗
分类号 R737.33 [医药卫生—肿瘤]
  • 相关文献

参考文献16

  • 1Chung HH, Kang W J, Kim JW, et al. The clinical impact of [ (18) F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings. European journal of nuclear medicine and molecular imaging, 2008, 35: 1081-1088. 被引量：1
  • 2Sohaib SA, Houghton SL, Meroni R, et al. Recurrent endometrial cancer ~ patterns of recurrent disease and assessment of prognosis. Clinical radiology, 2007, 62: 28-34. 被引量：1
  • 3王茜,洪莲,王建六,岳明纲,李河北,李原.^18F—FDG符合线路显像与肿瘤标志物检测对复发性子宫内膜癌的诊断价值[J].中华肿瘤杂志,2010,32(4):300-303. 被引量：3
  • 4Rauh-Hain JA, Del Carmen MG. Treatment for advanced and recurrent endometrial carcinoma: combined modalities. The oncologist, 2010, 15: 852-861. 被引量：1
  • 5Fleisch MC, Pantke P, Beckmann MW, et al. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. Journal of surgical oncology, 2007, 95: 476-484. 被引量：1
  • 6Bristow RE, Santillan A, Zahurak ML, et al. Salvage cytoreductive surgery for recurrent endometrial cancer. Gynecologic oncology, 2006, 103: 281-287. 被引量：1
  • 7Makker V, Hensley ML, Zhou Q, et al. Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009. International journal of gynecological cancer: official Journal of the International Gynecological Cancer Society, 2013, 23: 929-934. 被引量：1
  • 8Altman AD, Thompson J, Nelson G, et al. Use of aromatase inhibitors as first- and second-line medical therapy in patients with endometrial adenocarcinoma: a retrospective study. Journal of obstetrics and gynaecology Canada: JOGC Journal d'obstetrique et gynecologie du Canada: JOGC, 2012, 34: 664-672. 被引量：1
  • 9Barker LC, Brand IR, Crawford SM. Sustained effect of the aromatase inhibitors anastrozole and letrozole on endometrial thickness in patients with endometrial hyperplasia and endometrial carcinoma. Current medical research and opinion, 2009, 25: 1105-1109. 被引量：1
  • 10Dellinger TH, Monk BJ. Systemic therapy for recurrent endometrial cancer: a review of North American trials. Expert review of anticancertherapy, 2009, 9: 905-916. 被引量：1

二级参考文献7

  • 1Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009.CA Cancer J Clin,2009,59:225-249. 被引量：1
  • 2Bristow RE,Santillan A,Zahurak ML,et al.Salvage cytoreductive surgery for recurrent endometrial cancer.Gynecol Oncol,2006,103:281-287. 被引量：1
  • 3Kitajima K,Murakami K,Yamasaki E,et al.Performance of FDG-PET/CT in the diagnosis of recurrent endometrial cancer.Ann Nucl Med,2008,22:103-109. 被引量：1
  • 4Chung HH,Kang WJ,Kim JW,et al.The clinical impact of[18F]FDG PET/CT for the management of recurrent endometrial cancer:correlation with clinical and histological findings.Eur J Nucl Med Mol Imaging,2008,35:1081-1088. 被引量：1
  • 5Alschibaja M,Wegner M,Massmann J,et al.Prostate cancer volume:can it be predicted preoperatively? Urol Int,2005,75:354-359. 被引量：1
  • 6Furihata T,Sawada T,Kita J,et al.Serum alpha-fetoprotein level per tumor volume reflects prognosis in patients with hepatocellular carcinoma after curative hepatectomy.Hepatogastroenterology,2008,55:1705-1709. 被引量：1
  • 7Kumar P,Rehani MM,Kumar L,et al.Tumor marker CA-125 as an evaluator and response indicator in ovarian cancer:its quantitative correlation with tumor volume.Med Sci Monit,2005,11:CR84-89. 被引量：1

共引文献2

中国妇产科临床杂志
2015年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部